FDA proposes $22 million in user fees

02/20/2006 | Boston Globe (tiered subscription model), The

The FDA has requested that Congress approve $22 million in new user fees to be paid by medical device and drug companies whose facilities require reinspection by the agency. Although the policy might encourage companies to clean up FDA violations in their plants more quickly, the reinspection fees could mean significant costs for the companies.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN